Closing KOSN (Kosan) outperform
I liked this company but the market didn't. Apparently Bristol-Myers agreed with me and not the market. Quite a nice pick-up for Bristol-Myers considering the discount the market gave them in the absence of any negative catalysts. I don't see much movement from here so I'll simplify my CAPS portfolio and close the pick.